266 related articles for article (PubMed ID: 35763080)
21. Arabinoxylan ameliorates type 2 diabetes by regulating the gut microbiota and metabolites.
Nie Q; Hu J; Chen H; Geng F; Nie S
Food Chem; 2022 Mar; 371():131106. PubMed ID: 34543925
[TBL] [Abstract][Full Text] [Related]
22. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
23. A Mechanistic Model of Gut-Brain Axis Perturbation and High-Fat Diet Pathways to Gut Microbiome Homeostatic Disruption, Systemic Inflammation, and Type 2 Diabetes.
Lew KN; Starkweather A; Cong X; Judge M
Biol Res Nurs; 2019 Jul; 21(4):384-399. PubMed ID: 31113222
[TBL] [Abstract][Full Text] [Related]
24. Xenometabolite signatures in the UC Davis type 2 diabetes mellitus rat model revealed using a metabolomics platform enriched with microbe-derived metabolites.
Mercer KE; Yeruva L; Pack L; Graham JL; Stanhope KL; Chintapalli SV; Wankhade UD; Shankar K; Havel PJ; Adams SH; Piccolo BD
Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G157-G169. PubMed ID: 32508155
[TBL] [Abstract][Full Text] [Related]
25. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
[TBL] [Abstract][Full Text] [Related]
26. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
[TBL] [Abstract][Full Text] [Related]
27. Metabolomics applied to diabetes-lessons from human population studies.
Liggi S; Griffin JL
Int J Biochem Cell Biol; 2017 Dec; 93():136-147. PubMed ID: 29074437
[TBL] [Abstract][Full Text] [Related]
28. The Depletion of Carbohydrate Metabolic Genes in the Gut Microbiome Contributes to the Transition From Central Obesity to Type 2 Diabetes.
Jia R; Huang M; Qian L; Yan X; Lv Q; Ye H; Ye L; Wu X; Chen W; Chen Y; Jia Y; Huang Y; Wu H
Front Endocrinol (Lausanne); 2021; 12():747646. PubMed ID: 34745012
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Effectiveness of
Wang L; Yang C; Song F; Liu Z; Liu S
J Agric Food Chem; 2020 Sep; 68(36):9673-9682. PubMed ID: 32790297
[No Abstract] [Full Text] [Related]
30. Metabolomics Signatures in Type 2 Diabetes: A Systematic Review and Integrative Analysis.
Sun Y; Gao HY; Fan ZY; He Y; Yan YX
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31782507
[TBL] [Abstract][Full Text] [Related]
31. Metabolite patterns link diet, obesity, and type 2 diabetes in a Hispanic population.
Parnell LD; Noel SE; Bhupathiraju SN; Smith CE; Haslam DE; Zhang X; Tucker KL; Ordovas JM; Lai CQ
Metabolomics; 2021 Sep; 17(10):88. PubMed ID: 34553271
[TBL] [Abstract][Full Text] [Related]
32. Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes.
Gar C; Rottenkolber M; Prehn C; Adamski J; Seissler J; Lechner A
Crit Rev Clin Lab Sci; 2018 Jan; 55(1):21-32. PubMed ID: 29239245
[TBL] [Abstract][Full Text] [Related]
33. Untargeted metabolomics analysis on Cicer arietinium L.-Induced Amelioration in T2D rats by UPLC-Q-TOF-MS/MS.
Lin L; Zhang S; Lin Y; Liu W; Zou B; Cai Y; Liu D; Sun Y; Zhong Y; Xiao D; Liao Q; Xie Z
J Ethnopharmacol; 2020 Oct; 261():113013. PubMed ID: 32526338
[TBL] [Abstract][Full Text] [Related]
34. Oligosaccharides derived from
Liu H; Zhang Z; Li J; Liu W; Warda M; Cui B; Abd El-Aty AM
Food Funct; 2022 May; 13(9):5416-5429. PubMed ID: 35475434
[TBL] [Abstract][Full Text] [Related]
35. Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats.
Yan Z; Wu H; Zhou H; Chen S; He Y; Zhang W; Chen T; Yao H; Su W
Sci Rep; 2020 Jul; 10(1):10829. PubMed ID: 32616735
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
37. CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics.
Li H; Shi X; Jiang H; Kang J; Yu M; Li Q; Yu K; Chen Z; Pan H; Chen W
J Cell Mol Med; 2020 Jul; 24(13):7417-7426. PubMed ID: 32469143
[TBL] [Abstract][Full Text] [Related]
38. Metabolic and proteomic signatures of hypoglycaemia in type 2 diabetes.
Halama A; Kahal H; Bhagwat AM; Zierer J; Sathyapalan T; Graumann J; Suhre K; Atkin SL
Diabetes Obes Metab; 2019 Apr; 21(4):909-919. PubMed ID: 30525282
[TBL] [Abstract][Full Text] [Related]
39. Obese Individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and Composition.
Thingholm LB; Rühlemann MC; Koch M; Fuqua B; Laucke G; Boehm R; Bang C; Franzosa EA; Hübenthal M; Rahnavard A; Frost F; Lloyd-Price J; Schirmer M; Lusis AJ; Vulpe CD; Lerch MM; Homuth G; Kacprowski T; Schmidt CO; Nöthlings U; Karlsen TH; Lieb W; Laudes M; Franke A; Huttenhower C
Cell Host Microbe; 2019 Aug; 26(2):252-264.e10. PubMed ID: 31399369
[TBL] [Abstract][Full Text] [Related]
40. Metabolomics in diabetes.
Zhang AH; Qiu S; Xu HY; Sun H; Wang XJ
Clin Chim Acta; 2014 Feb; 429():106-10. PubMed ID: 24321733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
